Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 11/20 | 0.70 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22698058 | 0.84 | AHR (0.55) | AHRDYRK1ASMN1; SMN2ALOX5KDM4E | |
| SCHEMBL24956001 | 0.84 | AHR (0.55) | AHRDYRK1ASMN1; SMN2TTRKDM4E | |
| SCHEMBL13935846 | 0.83 | AHR (0.50) | AHRDYRK1ASMN1; SMN2ALOX5TTR | |
| SCHEMBL23765075 | 0.83 | AHR (0.50) | AHRSMN1; SMN2MAPTNPC1RAB9A | |
| SCHEMBL23690156 | 0.82 | AHR (0.68) | AHRSMN1; SMN2ALOX5TTRKDM4E | |
| SCHEMBL2286537 | 0.82 | AHR (1.00) | AHRSMN1; SMN2TTR | |
| SCHEMBL24958522 | 0.81 | AHR (0.49) | AHRDYRK1AALDH1A1 | |
| SCHEMBL24958277 | 0.81 | AHR (0.57) | AHRSMN1; SMN2ALOX5KDM4EMEN1 | |
| SCHEMBL24958663 | 0.81 | AHR (0.57) | AHRDYRK1ASMN1; SMN2ALOX5KDM4E | |
| SCHEMBL24955932 | 0.81 | AHR (0.49) | AHRDYRK1ASMN1; SMN2TTRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| WO-2023287228-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| US-20220416174-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2022045743-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, NR1D1 | AHR 18/4885DYRK1A 4247/4885SMN1; SMN2 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.